Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 13 | 3,904 | 49,169 | 17,269 | 17,274 |
| Gross Profit | 13 | 3,904 | 49,169 | 17,269 | 17,274 |
| Operating Expenses | 8,198 | 9,682 | 26,958 | 20,488 | 20,236 |
| Operating Income | -8,186 | -5,779 | 22,210 | -3,220 | -2,962 |
| Other Income | 105 | 103 | 146 | 78 | 60 |
| Pre-tax Income | -8,081 | -5,675 | 22,357 | -3,142 | -2,902 |
| Net Income Continuous | -8,081 | -5,675 | 22,357 | -3,142 | -2,902 |
| Net Income | $-8,081 | $-5,675 | $22,357 | $-3,142 | $-2,902 |
| EPS Basic Total Ops | -0.17 | -0.14 | 0.54 | -0.09 | -0.08 |
| EPS Basic Continuous Ops | -0.18 | -0.14 | 0.54 | -0.09 | -0.08 |
| EPS Diluted Total Ops | -0.16 | -0.14 | 0.52 | -0.09 | -0.08 |
| EPS Diluted Continuous Ops | -0.16 | -0.14 | 0.52 | -0.09 | -0.08 |
| EBITDA(a) | $-7,655 | $-5,064 | $22,895 | $-2,677 | $-2,426 |